Rapid paracellular transmigration of Campylobacter jejuni across polarized epithelial cells without affecting TER: role of proteolytic-active HtrA cleaving E-cadherin but not fibronectin
- Manja Boehm†1,
- Benjamin Hoy†2,
- Manfred Rohde†3,
- Nicole Tegtmeyer1,
- Kristoffer T Bæk4,
- Omar A Oyarzabal5,
- Lone Brøndsted4,
- Silja Wessler2 and
- Steffen Backert1, 6, 7Email author
© Boehm et al.; licensee BioMed Central Ltd 2012
Received: 6 April 2012
Accepted: 25 April 2012
Published: 25 April 2012
Campylobacter jejuni is one of the most important bacterial pathogens causing food-borne illness worldwide. Crossing the intestinal epithelial barrier and host cell entry by C. jejuni is considered the primary reason of damage to the intestinal tissue, but the molecular mechanisms as well as major bacterial and host cell factors involved in this process are still widely unclear.
In the present study, we characterized the serine protease HtrA (high-temperature requirement A) of C. jejuni as a secreted virulence factor with important proteolytic functions. Infection studies and in vitro cleavage assays showed that C. jejuni’s HtrA triggers shedding of the extracellular E-cadherin NTF domain (90 kDa) of non-polarised INT-407 and polarized MKN-28 epithelial cells, but fibronectin was not cleaved as seen for H. pylori’s HtrA. Deletion of the htrA gene in C. jejuni or expression of a protease-deficient S197A point mutant did not lead to loss of flagella or reduced bacterial motility, but led to severe defects in E-cadherin cleavage and transmigration of the bacteria across polarized MKN-28 cell layers. Unlike other highly invasive pathogens, transmigration across polarized cells by wild-type C. jejuni is highly efficient and is achieved within a few minutes of infection. Interestingly, E-cadherin cleavage by C. jejuni occurs in a limited fashion and transmigration required the intact flagella as well as HtrA protease activity, but does not reduce transepithelial electrical resistance (TER) as seen with Salmonella, Shigella, Listeria or Neisseria.
These results suggest that HtrA-mediated E-cadherin cleavage is involved in rapid crossing of the epithelial barrier by C. jejuni via a very specific mechanism using the paracellular route to reach basolateral surfaces, but does not cleave the fibronectin receptor which is necessary for cell entry.
KeywordsHtrA E-cadherin Fibronectin MKN-28 Molecular pathogenesis Cellular invasion Signaling TER Virulence
Infections with pathogenic food-borne bacteria constitute one of the leading causes of morbidity and mortality in humans. The World Health Organization (WHO) suggests that the human population worldwide suffers from about 4.5 billion incidences of gastroenteritis annually, causing approximately 1.8 million deaths . Various Campylobacter species have been identified as the leading enteric bacterial infection worldwide [2, 3]. Campylobacter jejuni is considered as a classical zoonotic pathogen, as it is found in the normal intestinal flora in many birds and mammals. Since C. jejuni colonizes various food animals, it can contaminate food products during processing . After ingestion by a human host, these bacteria use their flagella-driven motility to colonize the epithelial cells of the ileum and colon. Here, they can interfere with normal functions in the intestinal tract, leading to diseases associated with fever, malaise, abdominal pain and watery diarrhoea [2, 3]. In addition, a minority of infected individuals may develop late complications such as Reiter’s reactive arthritis or Guillain-Barrè and Miller-Fisher syndromes . There is increasing evidence showing that C. jejuni disturbs the normal absorptive capacity of the human intestine by damaging epithelial cell functions, either by cell invasion, the production of pathogenicity-associated factors or indirectly by triggering inflammatory responses [3, 6–8].
It has been proposed that transmigration across and invasion into intestinal epithelial cells during infection is a major reason of C. jejuni-triggered tissue damage [2–4]. Investigation of gut biopsies obtained from infected patients and in vitro infection experiments of intestinal epithelial cells indicated that C. jejuni can enter human host cells [9–11]. Campylobacter jejuni expresses various adhesins in the outer-membrane including CadF, FlpA, JlpA and PEB1 [12–15]. For example, in vitro CadF is a well-known bacterial factor that binds to fibronectin, an important extracellular matrix (ECM) protein and bridging factor to integrin receptors [13, 16, 17]. Maximal bacterial adherence and invasion of INT-407 intestinal epithelial cells is dependent on CadF and is associated with tyrosine phosphorylation of paxillin, a focal adhesion-based scaffolding factor . The expression of CadF also seems to be required for the stimulation of the small Rho GTPases Rac1 and Cdc42 via fibronectin and integrin member β1, that are required for C. jejuni host cell entry. The signalling pathways involved in the latter process have been described in detail [19–21]. However, fibronectin and integrin β1 are basolateral receptor molecules and not commonly exposed at apical surfaces in the intestine. It is therefore unclear how C. jejuni gains access to these receptors during infection.
To access deeper tissues and cause short- or long-term infections in the human body, various pathogenic bacteria, including Salmonella, Shigella Listeria or Neisseria, must overcome the epithelial barrier [22, 23]. These important bacterial pathogens are able to cross polarised intestinal epithelial cells by different mechanisms, known as the paracellular and the transcellular routes. Bacteria using the transcellular route enter host cells at apical surfaces followed by intracellular trafficking and leave these cells at the basolateral surface. In contrast, bacteria specialised on the paracellular route cross the epithelial barrier by passage between neighbouring epithelial cells and overcome the tight junctions and adherens junctions . In the case of C. jejuni, the literature is highly controversial. While some groups reported the paracellular route, others described the transcellular model or a mix of both [25–30]. In general, the host factors and bacterial factors involved in the transmigration process of C. jejuni are still unclear .
We have recently shown that a closely related pathogen, Helicobacter pylori, secretes a novel bacterial virulence determinant into the culture supernatant, the serine protease HtrA [32–34], which is also present in C. jejuni[35–37]. HtrA proteins constitute a group of heat shock induced serine proteases that influence the adhesion and invasion properties of different bacterial pathogens. HtrA proteins typically consist of a signal peptide, a trypsin-like serine protease domain and one or two protein interaction (PDZ) domains. In addition, by binding of the PDZ domain in one HtrA molecule to that in other HtrA molecules, HtrA can build-up to highly proteolytic active oligomers that also function as a chaperone . The HtrA protease domain consists of an active site, called the catalytic triad, which is formed by the conserved amino acid residues histidine, aspartatic acid and serine . Many bacterial HtrA proteins are suggested to be localized in the periplasm and to be involved in quality control of envelope proteins by degradation of misfolded proteins as well as prevention of formation of aggregates . Thus, it was surprising to find that HtrA exhibits the capability of extracelluar transport in H. pylori[34, 41], where it could cleave host surface molecules. We identified that H. pylori HtrA directly cleaves the junctional protein and tumor suppressor E-cadherin and fibronectin on the surface of gastric epithelial host cells. HtrA-mediated cleavage of E-cadherin facilitated the loss of the adherence junction complex leading to the disruption of the epithelial barrier function in response to H. pylori infection  and may also apply to C. jejuni HtrA . Here, we present the results from a detailed investigation to determine if C. jejuni HtrA can cleave both E-cadherin and fibronectin, and whether HtrA protease activity is required for transmigration across polarised epithelial cells. Our findings show that C. jejuni can effectively cross polarised epithelial cells in an HtrA-protease dependent fashion without affecting TER.
Results & discussion
HtrA protease is conserved in H. pylori and C. jejuni
Recently, HtrA of the gastric pathogen H. pylori was reported to be specifically secreted into the cell culture supernatant, where it can cleave the ectodomain of the host cell adhesion protein and tumour-suppressor E-cadherin, and degrades fibronectin . A sequence alignment of HtrAs from different C. jejuni and H. pylori strains was performed and revealed a high degree of similarity between the HtrA domains and protein sequences (Additional file 1: Figure S1A). We also found that the amino acids in the catalytic triad (histidine, aspartate and serine) are conserved and at the expected position among these proteins ( Additional file 1: Figure S1B, shaded with yellow). These results suggest that HtrA’s are highly conserved in various C. jejuni isolates. We therefore suspected that C. jejuni may also use its HtrA protease to cross the barrier of polarised epithelial cells.
Analysis of wild-type and htrA mutant C. jejuni by electron microscopy and motility assays
HtrA’s of strains 81–176 and NCTC11168 form active multimers
Multiple C. jejuni wt strains express active HtrA multimers
To exclude the possibility that HtrA activity is restricted to the above C. jejuni isolates, we tested a larger collection of wt strains for their expression of active HtrA proteins. Total cell lysates from C. jejuni wt RM1221, ATCC43430, TGH-9011, 1849, 1543/01, 2703/01 and ST3046 were prepared and analyzed for HtrA protease activities by casein zymography. All tested strains expressed the active HtrA multimer with a molecular size of ~200 kDa, albeit at various extent, while only faint bands of the monomer at ~53 kDa were seen (Figure 3B). We could also confirm previous findings that these native C. jejuni HtrA’s were very similar to recombinant H. pylori HtrA forming highly active multimers at the same size ~200 kDa  (Figure 3B, lane 1).
C. jejuni secretes HtrA into the culture supernatant where they form active multimers
In vitro cleavage properties of purified HtrA’s of C. jejuni and H. pylori
H. pylori HtrA has recently been shown to cleave the cell adhesion protein E-cadherin and the extracellular matrix protein fibronectin . Full length E-cadherin has a molecular weight of about 130 kDa and is composed of a ~90 kDa extracellular domain amino-terminal fragment (NTF) and a ~40 kDa carboxy-terminal fragment (CTF1) . To determine whether C. jejuni HtrA can cleave E-cadherin into specific subfragments recombinant HtrAs was purified. As expected, C. jejuni HtrA had slightly different molecular weight as compared to its H. pylori counterpart, due to the smaller size of the expressed protein (472 vs. 476 amino acids) (Additional file 1: Figure S3). Recombinant C. jejuni HtrA was then incubated with recombinant full-length E-cadherin. The ectodomain shedding of E-cadherin was detected using α-E-cadherin antibodies recognising the EC5 subunit in the NTF domain. Like its H. pylori counterpart, it was shown that C. jejuni HtrA cleaved E-cadherin as monitored by the disappearance of full-length protein band and increasing amounts of the ~90 kDa NTF domain (Figure 4B /C). In addition, we performed assays with the purified recombinant NTF domain (amino acids 1–707 followed by a His-tag) showing that this domain disappears upon HtrA cleavage as shown by anti-E-cadherin and anti-His blots, indicating that the cleavage site of HtrA is indeed in the extracellular part of E-cadherin adjacent to the transmembrane domain (amino acids 711–731) (Figure 4C /D). Interestingly, E-cadherin ectodomain cleavage by C. jejuni HtrA was not as efficient as compared to H. pylori HtrA, but band sizes were similar, albeit with different intensity. Moreover, H. pylori HtrA cleaved purified fibronectin into multiple subfragments, while C. jejuni HtrA did not cleave fibronectin at all (Figure 4E). These observations suggest that although HtrA from H. pylori and C. jejuni share substantial sequence homology, significant differences exist for certain host substrates. The above experiments were all performed at 37°C, which is the body temperature of mammalian hosts. However, since C. jejuni also exhibits host specificity for avian species (42°C), we tested if HtrA exhibits different cleavage properties at 42°C. Interestingly, the cleavage patterns were identical between 37°C and 42°C (Figure 4C /D and Additional file 1: Figure S4).
In vivo cleavage of E-cadherin in C. jejuni infected INT-407 or MKN-28 cells
Wild-type C. jejuni transmigrate efficiently across polarised MKN-28 monolayers but do not reduce TER
C. jejuni ΔhtrA and S197A point mutants have a strong defect in transmigration
The intestinal mucosa in the human intestine forms a tight barrier, which protects against host invasion by commensals, non-pathogenic microbes residing in the intestinal lumen. Some enteric pathogenic bacteria, such as Salmonella Shigella, or Listeria, have specific tissue-invading properties and can physically breach the intestinal mucosal barrier [43–45]. In general, these bacterial pathogens can translocate via a paracellular route or a transcellular route. A well studied example is Salmonella enterica serovar Typhimurium which can cross the intestinal barrier preferentially by entering M cells, although they can also enter and pass through epithelial cells of the intestinal tract in vivo and in cultured polarized epithelial cells in vitro [46–48]. However, very little is known about C. jejuni transmigration. Previous work has revealed that C. jejuni can translocate across Caco-2 and other polarized cell monolayers without a concomitant loss in TER [25, 49–51], indicating that C. jejuni can cross a given polarised cell monolayer whose integrity, however, remains intact. In contrast, other research groups reported on a time-dependent decrease of TER caused by C. jejuni infection, while the bacterial factor(s) triggering a reduction in TER were not addressed [52–54]. Thus, there are some conflicting data in the literature and a consensus is yet to be reached among investigators as to the mechanism of translocation.
Our previous data suggested that HtrA chaperone activity plays a major role in C. jejuni host cell binding, whereas HtrA protease activity mainly affected invasion . Novel data presented in this work show that HtrA from C. jejuni can be secreted into the cell culture supernatant during bacterial growth or during infection. In addition, it was shown that C. jejuni can cross polarised epithelial monolayers very rapidly. The first viable transmigrated wt C. jejuni CFU were detected after 15–30 min (Figure 6 and data not shown). In contrast, C. jejuni invasion of different host cell types was commonly observed at much later time points and was obvious between 4–6 hours or later during infection [18–21, 55, 56]. These facts alone already indicate that transmigration of C. jejuni exclude the transcellular route as a major mechanism in MKN-28 cells, which would of course take much longer time until the first bacteria reach the basolateral compartment. Instead, our findings strongly argue for the paracellular route mainly used by C. jejuni 81– 176 and NCTC11168. Moreover, it was found that deletion of htrA or complementation with a protease-inactive S197A mutant exhibited a strongly reduced transmigration potential, indicating that HtrA’s protease activity indeed plays a role in this process. In addition, all htrA mutants described here expressed flagella and were highly motile. Thus, we describe here the first C. jejuni mutants with very high motility, but having very low transmigration and invasion potential, thus behaving like a classical avirulent ΔflaA/B mutant.
In addition, evidence was presented that recombinant HtrA from C. jejuni can cleave-off in vitro and during infection in vivo the NTF domain from E-cadherin, a major adherens junctional protein, while it leaves the receptor molecule fibronectin uncleaved. Thus, cleavage of E-cadherin may be involved in C. jejuni transmigration. The exact cleavage site(s) in E-cadherin, however, are yet unknown and should be investigated in future studies. In addition, the total amount of cell-based E-cadherin dropped down during the course of infection, but did not lead to a complete cleavage, even at late time points of infection (8 hours). We therefore propose that cleavage of E-cadherin by HtrA during infection is a strictly controlled, temporary and locally restricted process, possibly achieved by surface-exposed and/or secreted HtrA proteins when the bacteria enter the intercellular space. Host cells continuously translate large amounts of E-cadherin proteins, and therefore the host cell machinery could rapidly replace cleaved proteins. This hypothesis could also explain why no significant reduction in TER was observed during infection with C. jejuni, and suggests that these bacteria can close the “door” behind them, which appears as a clever novel infection mechanism during bacterial transmigration across polarised gut epithelial cells.
The C. jejuni strains RM1221, ATCC43430, TGH-9011, NCTC11168, 1849, 81–176, 1543/01, 2703/01, ST3046 and F38011 were used in this study. The isogenic mutants 81-176ΔcadF, 11168ΔhtrA and 11168htrA S197A were recently described [33, 35–37]. The isogenic F38011ΔcadF and 81-176ΔflaA/B mutants were kindly provided by Michael Konkel  and Patricia Guerry . All C. jejuni strains were grown on Campylobacter blood-free selective Agar Base (Oxoid) containing Campylobacter growth supplement (Oxoid) or on Mueller-Hinton (MH) agar amended with 50 μg/ml kanamycin or 30 μg/ml or chloramphenicol at 37°C under microaerobic conditions (generated by CampyGen, Oxoid) for 48 hours.
Other bacterial species
Salmonella typhimurium strain NCTC12023 was kindly provided by M. Hensel (University Osnabrueck/Germany). Neisseria gonorrhoeae strain 6B10 is a gift of T. Meyer (Max Planck Institute for Infection Biology Berlin/Germany). Shigella flexneri strain 15.4 is a clinical isolate from the Medical School Magdeburg/Germany, and Listeria monocytogenes strain EGD (Serotyp 1/2a) was kindly provided by J. Wehland (HZI Braunschweig/Germany). As control, we used the non-pathogenic Escherichia coli strain Top10 (Invitrogen). Each of these bacteria was grown overnight at 37°C on conventional LB agar plates.
HtrA secretion assays
C. jejuni wild-type and ΔhtrA deletion mutant strains were grown in BHI broth medium for 12 hours to an OD600nm ~1.0. The supernatant and the cell pellets were separated by centrifugation at 4,000 rpm, and the supernatant was further purified from remaining bacterial cells by passage through a 0.21 μm sterile filter. The resulting bacterial pellets and supernatants were analysed by immunoblot and casein zymography analyses. Absence of live bacteria in the supernatant was confirmed by incubation on agar plates showing no growth.
Motility phenotypes of strains were tested in MH media containing 0.4% agar. Bacterial cells were harvested from a 36 h culture on conventional agar plates and resuspended in PBS to obtain an optical density at 600 nm of 0.45 (approximately 1 × 109 CFU/ml). Subsequently, 2 μl of a bacterial suspension of 2 × 108 CFU/ml were stabbed into motility agar. Plates were incubated at 37°C under microaerophilic conditions for 36 h, followed by measuring the diameter of the resulting swarms. The final data were the mean of at least five separate measurements from three experiments.
Host cell lines
Human embryonic intestinal epithelial cells (INT-407, non-polarised), obtained from the American Type Culture Collection (ATCC CCL-6) and polarised MKN-28 cells were grown in RPMI-1640 medium containing L-glutamine and Earle’s salts (Gibco). After reaching about 70% confluency, the cells were washed two times with PBS, and then starved for 12 h before infection.
For the infection experiments, INT-407 cells were seeded to give 4 × 105 CFU in 12-well tissue culture plates. The culture medium was replaced with fresh medium without antibiotics 1 h before infection. Bacteria were suspended in culture medium, added to the cells at a multiplicity of infection (MOI) of 100, and co-incubated with host cells for the indicated periods of time per experiment.
Transepithelial electrical resistance (TER) assay
MKN-28 cells were cultured on 0.33 cm² cell culture inserts with 3 μm pore size (Millipore). The cells were allowed to form confluent monolayers, and then incubated for another 14 days. TER was measured with an Electrical Resistance System (ERS) (Millipore). Maximum resistance indicated that the cells reached maximal polarity. TER was calculated as Ohms x cm² by subtracting fluid resistance and multiplying by the monolayer surface area. Bacteria were suspended in culture medium, added to the cells at a multiplicity of infection (MOI) of 50, and co-incubated with host cells for the indicated periods of time per experiment. The number of CFU was determined by growth on MH or LB plates, respectively.
HtrA expression, purification and E-cadherin cleavage in vitro
Cloning of H. pylori htrA (Hp HtrA aa18-aa475) and C. jejuni htrA (CjHtrA aa17-aa472) was described previously [33, 34]. Briefly, the genes were amplified from genomic DNA excluding predicted signal peptides. PCR fragments flanked by restriction sites for Bam HI/Xma I were cloned into pGEX-6P-1 (GE Healthcare) to generate a GST-fusion protein. The expression and purification protocol was described in detail . Cleavage assays of purified HtrA with recombinant human full-length E-cadherin (R&D Systems), recombinant human His-tagged N-terminal NTF domain (Sino Biological) or human fibronectin (Calbiochem) were performed as described .
SDS-PAGE and western blot
Cells were lysed , proteins were separated by SDS-PAGE and tested for fibronectin (Santa Cruz) and E-cadherin using polyclonal antibodies recognizing the extracellular domain of E-cadherin (H-108 from Santa Cruz or HECD1 from BD Biosciences) and whole cell lysates were tested for GAPDH. The polyclonal anti-His tag antibody is from Qiagen and the rabbit HtrA antibody was described in [36, 37]. Bacterial HtrAs were detected by Coomassie staining (BioRad).
Bacterial lysates, culture supernatants or recombinant HtrA were separated in casein containing gels under non-reducing conditions. Subsequently, gels were renatured in 2.5% Triton-X-100 and equilibrated in developing buffer . Caseinolytic activity was visualized by staining with 0.5% Coomassie Blue R250.
Field emission scanning electron microscopy (FESEM)
Plate-grown C. jejuni strains were harvested and fixed in a sterile solution containing 5% formaldehyde, 2% glutaraldehyde in cacodylate buffer (0.1 M cacodylate, 0.01 M CaCl2, 0.01 M MgCl2, 0.09 M sucrose, pH 6.9) for 1 hour on ice. The solution was centrifuged and passed through a sterile filter. After several washes with cacodylate buffer and TE buffer (20 mM Tris, 1 mM EDTA, pH 6.9), samples were dehydrated in serial dilutions of acetone (10, 30, 50, 70, 90 and 100%) on ice for 15 min each step. Samples were then allowed to reach room temperature before another change of 100% acetone, after which they were subjected to critical-point drying with liquid CO2 (CPD030, Bal-Tec). Samples were finally covered with ca. 10.0-nm 11 thick gold film by sputter coating (SCD500, Bal-Tec) and examined in a field emission scanning electron microscope (Zeiss DSM 982 Gemini) using an Everhart Thornley SE detector and in-lens detector in a 50:50 ratio at an acceleration voltage of 5.0 kV.
Electron microscopic analysis by negative staining
For negative staining, thin carbon support films were prepared by indirect sublimation of carbon on freshly cleaved mica. Samples were then absorbed to the carbon film and negatively stained with 1% (wt/vol) aqueous uranyl acetate (pH 4.5). After air drying, samples were examined by transmission electron microscopy (TEM) in a Zeiss TEM 910 at an acceleration voltage of 80 kV.
All data were evaluated using Student t-test with SigmaStat statistical software (version 2.0). Statistical significance was defined by P ≤ 0.05 (*) and P ≤ 0.005 (**). All error bars shown in figures and those quoted following the +/− signs represent standard deviations.
We thank Ina Schleicher (HZI Braunschweig, Germany), Dr. Sabine Brandt (University Magdeburg, Germany) and Dr. Marguerite Clyne (UCD Dublin, Ireland) for technical support. We also thank Drs. Patricia Guerry (Fayetteville State University, USA), Michael Konkel (Pullman University, USA), Michael Hensel (University Osnabrueck, Germany), Thomas Meyer (Max Planck Institute for Infection Biology Berlin, Germany) and Juergen Wehland (HZI Braunschweig, Germany) for providing the indicated pathogens. The work of S.B. is supported through a SFI grant (UCD 09/IN.1/B2609).
- World Health Organization: Global burden of disease (GBD) 2002 estimates. WHO, 2004, Geneva, Switzerland,http://www.who.int/topics/global_burden_of_disease/en/
- Young KT, Davis LM, DiRita VJ: Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol. 2007, 5: 665-679. 10.1038/nrmicro1718.View ArticlePubMed
- Nachamkin I: Szymanski CM, Blaser MJ: Campylobacter. ASM Press, Washington, DC, 2008.
- Oyarzabal OA, Backert S: Microbial Food Safety: An Introduction. Springer Verlag, Heidelberg (Germany), in press
- Blaser MJ, Engberg J: Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. Campylobacter. Edited by: Nachamkin I, Szymanski CM, Blaser MJ. 2008, ASM Press, Washington, DC, 99-121. 3View Article
- Ketley JM: Pathogenesis of enteric infection by Campylobacter. Microbiology. 1997, 143: 5-21. 10.1099/00221287-143-1-5.View ArticlePubMed
- Wooldridge KG, Ketley JM: Campylobacter-host cell interactions. Trends Microbiol. 1997, 5: 96-102. 10.1016/S0966-842X(97)01004-4.View ArticlePubMed
- Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U: Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010, 300: 205-211. 10.1016/j.ijmm.2009.07.002.View ArticlePubMed
- van Spreeuwel JP, Duursma GC, Meijer CJ, Bax R, Rosekrans PC, Lindeman J: Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut. 1985, 26: 945-951. 10.1136/gut.26.9.945.PubMed CentralView ArticlePubMed
- Oelschlaeger TA, Guerry P, Kopecko DJ: Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci USA. 1993, 90: 6884-6888. 10.1073/pnas.90.14.6884.PubMed CentralView ArticlePubMed
- Wooldridge KG, Williams PH, Ketley JM: Host signal transduction and endocytosis of Campylobacter jejuni. Microb Pathog. 1997, 21: 299-305.View Article
- Pei Z, Burucoa C, Grignon B, Baqar S, Huang XZ, Kopecko DJ, Bourgeois AL, Fauchere JL, Blaser MJ: Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun. 1998, 66: 938-943.PubMed CentralPubMed
- Konkel ME, Monteville MR, Rivera-Amill V, Joens LA: The pathogenesis ofCampylobacter jejuni-mediated enteritis. Curr Issues Intest Microbiol. 2001, 2: 55-71.PubMed
- Poly F, Guerry P: Pathogenesis of Campylobacter. Curr Opin Gastroenterol. 2008, 24: 27-31. 10.1097/MOG.0b013e3282f1dcb1.View ArticlePubMed
- Euker TP, Konkel ME: The cooperative action of bacterial fibronectin-binding proteins and secreted proteins promote maximal Campylobacter jejuni invasion of host cells by stimulating membrane ruffling. Cell Microbiol. 2012, 14: 226-238. 10.1111/j.1462-5822.2011.01714.x.View Article
- Moser I, Schroeder W, Salnikow J: Campylobacter jejuni major outer membrane protein and a 59-kDa protein are involved in binding to fibronectin and INT 407 cell membranes. FEMS Microbiol Lett. 1997, 157: 233-238. 10.1111/j.1574-6968.1997.tb12778.x.View ArticlePubMed
- Konkel ME, Gray SA, Kim BJ, Garvis SG, Yoon JJ: Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the cadF virulence gene and its product. Clin Microbiol. 1999, 37: 510-517.
- Monteville MR, Yoon JE, Konkel ME: Maximal adherence and invasion of INT 407 cells by Campylobacter jejuni requires the CadF outer-membrane protein and microfilament reorganization. Microbiology. 2003, 149: 153-165. 10.1099/mic.0.25820-0.View ArticlePubMed
- Krause-Gruszczynska M, Rohde M, Hartig R, Genth H, Schmidt G, Keo T, Koenig W, Miller WG, Konkel ME, Backert S: Role of small Rho GTPases Rac1 and Cdc42 in host cell invasion of Campylobacter jejuni. Cell Microbiol. 2007, 9: 2431-2444. 10.1111/j.1462-5822.2007.00971.x.View ArticlePubMed
- Krause-Gruszczynska M, Boehm M, Rohde M, Tegtmeyer N, Takahashi S, Buday L, Oyarzabal OA, Backert S: The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2. Cell Commun Signal. 2011, 9: 32-10.3389/fcimb.2011.00017.PubMed CentralView ArticlePubMed
- Boehm M, Krause-Gruszczynska M, Rohde M, Tegtmeyer N, Takahashi S, Oyarzabal OA, Backert S: Major host factors involved in epithelial cell invasion of Campylobacter jejuni: Role of fibronectin, integrin beta1, FAK, Tiam-1 and DOCK180 in activating Rho GTPase Rac1. Front Cell Infect Microbiol. in press
- Kazmierczak BI, Mostov K, Engel JN: Interaction of bacterial pathogens with polarized epithelium. Annu Rev Microbiol. 2001, 55: 407-435. 10.1146/annurev.micro.55.1.407.View ArticlePubMed
- Tegtmeyer N, Wittelsberger R, Hartig R, Wessler S, Martinez-Quiles N, Backert S: Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori. Cell Host Microbe. 2011, 9: 520-531. 10.1016/j.chom.2011.05.007.View ArticlePubMed
- Balkovetz DF, Katz J: Bacterial invasion by a paracellular route: divide and conquer. Microbes Infect. 2003, 5: 613-619. 10.1016/S1286-4579(03)00089-3.View ArticlePubMed
- Konkel ME, Mead DJ, Hayes SF, Cieplak W: Translocation of Campylobacter jejuni across human polarized epithelial cell monolayer cultures. J Infect Dis. 1992, 166: 308-315. 10.1093/infdis/166.2.308.View ArticlePubMed
- Grant CCR, Konkel ME, Cieplak W, Tompkins LS: Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. Infect Immun. 1993, 61: 1764-1771.PubMed CentralPubMed
- Brás AM, Ketley JM: Transcellular translocation of Campylobacter jejuni across human polarised epithelial monolayers. FEMS Microbiol Lett. 1999, 179: 209-215.View ArticlePubMed
- Monteville MR, Konkel ME: Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface. Infect Immun. 2002, 70: 6665-6671. 10.1128/IAI.70.12.6665-6671.2002.PubMed CentralView ArticlePubMed
- Hu L, Tall BD, Curtis SK, Kopecko DJ: Enhanced microscopic definition of Campylobacter jejuni 81–176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells. Infect Immun. 2008, 76: 5294-5304. 10.1128/IAI.01408-07.PubMed CentralView ArticlePubMed
- Kalischuk LD, Inglis GD, Buret AG: Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog. 2009, 1: 2-10.1186/1757-4749-1-2.PubMed CentralView ArticlePubMed
- Ó Cróinín T, Backert S: Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism?. Front Cell Infect Microbiol. 10.3389/fcimb.2012.00025. in press
- Hoy B, Löwer M, Weydig C, Carra G, Tegtmeyer N, Geppert T, Schröder P, Sewald N, Backert S, Schneider G, Wessler S: Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010, 11: 798-804. 10.1038/embor.2010.114.PubMed CentralView ArticlePubMed
- Hoy B, Geppert T, Boehm M, Reisen F, Plattner P, Gadermaier G, Sewald N, Ferreira F, Briza P, Schneider G, Backert S, Wessler S: Distinct roles of secreted HtrA proteases from Gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem. in press
- Löwer M, Weydig C, Metzler D, Reuter A, Starzinski-Powitz A, Wessler S, Schneider G: Prediction of extracellular proteases of the human pathogen Helicobacter pylori reveals proteolytic activity of the Hp1018/19 protein HtrA. PLoS One. 2008, 3: e3510-10.1371/journal.pone.0003510.PubMed CentralView ArticlePubMed
- Brøndsted L, Andersen MT, Parker M, Jørgensen K, Ingmer H: The HtrA protease of Campylobacter jejuni is required for heat and oxygen tolerance and for optimal interaction with human epithelial cells. Appl Environ Microbiol. 2005, 71: 3205-3212. 10.1128/AEM.71.6.3205-3212.2005.PubMed CentralView ArticlePubMed
- Bæk KT, Vegge CS, Brøndsted L: HtrA chaperone activity contributes to host cell binding in Campylobacter jejuni. Gut Pathog. 2011, 3: 13-10.1186/1757-4749-3-13.PubMed CentralView ArticlePubMed
- Baek KT, Vegge CS, Skórko-Glonek J, Brøndsted L: Different contributions of HtrA protease and chaperone activities to Campylobacter jejuni stress tolerance and physiology. Appl Environ Microbiol. 2011, 77: 57-66. 10.1128/AEM.01603-10.PubMed CentralView ArticlePubMed
- Krojer T, Sawa J, Schäfer E, Saibil HR, Ehrmann M, Clausen T: Structural basis for the regulated protease and chaperone function of DegP. Nature. 2008, 453: 885-890. 10.1038/nature07004.View ArticlePubMed
- Kim DY, Kim KK: Structure and function of HtrA family proteins, the key players in protein quality control. J Biochem Mol Biol. 2005, 38: 266-274. 10.5483/BMBRep.2005.38.3.266.View ArticlePubMed
- Clausen T, Southan C, Ehrmann M: The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell. 2002, 10: 443-455. 10.1016/S1097-2765(02)00658-5.View ArticlePubMed
- Bumann D, Aksu S, Wendland M, Janek K, Zimny-Arndt U, Sabarth N, Meyer TF, Jungblut PR: Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun. 2002, 70: 3396-3403. 10.1128/IAI.70.7.3396-3403.2002.PubMed CentralView ArticlePubMed
- Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA, Israel DA, Turner JR, Peek RM: Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology. 2009, 136: 236-246. 10.1053/j.gastro.2008.10.011.PubMed CentralView ArticlePubMed
- Cossart P, Sansonetti PJ: Bacterial invasion: the paradigms of enteroinvasive pathogens. Science. 2004, 304: 242-248. 10.1126/science.1090124.View ArticlePubMed
- Rottner K, Stradal TE, Wehland J: Bacteria-host-cell interactions at the plasma membrane: stories on actin cytoskeleton subversion. Dev Cell. 2005, 9: 3-17. 10.1016/j.devcel.2005.06.002.View ArticlePubMed
- Backert S, König W: Interplay of bacterial toxins with host defense: molecular mechanisms of immunomodulatory signaling. Int J Med Microbiol. 2005, 295: 519-530. 10.1016/j.ijmm.2005.06.011.View ArticlePubMed
- Gerlach RG, Hensel M: Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica. Berl Munch Tierarztl Wochenschr. 2007, 120: 317-327.PubMed
- Stecher B, Hardt WD: The role of microbiota in infectious disease. Trends Microbiol. 2008, 16: 107-114. 10.1016/j.tim.2007.12.008.View ArticlePubMed
- Tsolis RM, Young GM, Solnick JV, Bäumler AJ: From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol. 2008, 6: 883-892. 10.1038/nrmicro2012.View ArticlePubMed
- Everest PH, Goossens H, Butzler JP, Lloyd D, Knutton S, Ketley JM, Williams PH: Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol. 1992, 37: 319-325. 10.1099/00222615-37-5-319.View ArticlePubMed
- Harvey P, Battle T, Leach S: Different invasion phenotypes of Campylobacter isolates in Caco-2 cell monolayers. J Med Microbiol. 1999, 48: 461-469. 10.1099/00222615-48-5-461.View ArticlePubMed
- Brás AM, Ketley JM: Transcellular translocation of Campylobacter jejuni across human polarised epithelial monolayers. FEMS Microbiol Lett. 1999, 179: 209-215.View ArticlePubMed
- Chen ML, Ge Z, Fox JG, Schauer DB: Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infect Immun. 2006, 74: 6581-6589. 10.1128/IAI.00958-06.PubMed CentralView ArticlePubMed
- Wine E, Chan VL, Sherman PM: Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion. Pediatr Res. 2008, 64: 599-604. 10.1203/PDR.0b013e31818702b9.View ArticlePubMed
- Pogacar MS, Klancnik A, Mozina SS, Cencic A: Attachment, invasion, and translocation of Campylobacter jejuni in pig small-intestinal epithelial cells. Foodborne Pathog Dis. 2010, 7: 589-595. 10.1089/fpd.2009.0301.View ArticlePubMed
- Biswas D, Niwa H, Itoh K: Infection with Campylobacter jejuni induces tyrosine-phosphorylated proteins into INT-407 cells. Microbiol Immunol. 2004, 48: 221-228.View ArticlePubMed
- Hu L, McDaniel JP, Kopecko DJ: Signal transduction events involved in human epithelial cell invasion by Campylobacter jejuni 81–176. Microb Pathog. 2006, 40: 91-100. 10.1016/j.micpath.2005.11.004.View ArticlePubMed
- Konkel ME, Garvis SD, Tipton S, Anderson DE, Cieplak W: Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter jejuni. Mol Microbiol. 1997, 24: 953-963. 10.1046/j.1365-2958.1997.4031771.x.View ArticlePubMed
- Goon S, Ewing CP, Lorenzo M, Pattarini D, Majam G, Guerry P: σ28-regulated nonflagella gene contributes to virulence of Campylobacter jejuni 81–176. Infect Immun. 2006, 74: 769-772. 10.1128/IAI.74.1.769-772.2006.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.